Literature DB >> 12077636

Management of hemorrhoidal disease in patients with chronic spinal cord injury.

D Scott1, M Z Papa, M Sareli, A Velano, G Y Ben-Ari, M Koller.   

Abstract

Hemorrhoidal disease is a common pathology in patients with chronic spinal cord injury (SCI). We describe our experience with the primary approach to this problem at the Proctology Division of the Sheba Medical Center. We treated 29 patients (26 men) with paraplegia due to SCI between 1995 and 1999. The mean age was 49 years (range, 22-74 years). All patients had hemorrhoids in stages ranging between II and IV. Main complaints were rectal bleeding (83%), difficulties in evacuation (38%) and discomfort or pain (28%). Eleven patients (38%) were treated conservatively (e. g. diet, hygiene and laxatives), while 18 patients (62%) underwent either banding or sclerotherapy of hemorrhoids or both. No major complication were observed. In 28 of 29 patients (96%), there was a significant reduction or cessation of bleeding and/or relief of symptoms; one patient (3%) required hemorrhoidectomy. Of the 28 successful treatments, 16 (57%) had partial reduction of bleeding or relief of symptoms, while in 12 (43%) response was complete. Of those who were treated conservatively, 9 (82%) had partial and 2 (18%) had complete relief of symptoms. Of those who had banding/sclerotherapy, 7 (41%) had partial and 10 (59%) had complete relief. We also examined the effect of perianal sensation on the treatment outcome. Of 16 patients with complete anesthesia, 11 (69%) had partial and 5 (31%) had complete relief, whereas of the 12 patients with preserved sensation, 5 (42%) had partial and 7 (58%) had complete relief. In conclusion, the approach of banding or sclerotherapy of hemorrhoids in SCI patients is safe and effective. When sensation of the perianal region is preserved, the outcome seems to be better. The cause of SCI has no impact on the treatment results. There was no difference in the outcome of treatment between patients with stage II and stage III hemorrhoids; patients with stage IV hemorrhoids seem to do worse than those with stages II and III.

Entities:  

Mesh:

Year:  2002        PMID: 12077636     DOI: 10.1007/s101510200003

Source DB:  PubMed          Journal:  Tech Coloproctol        ISSN: 1123-6337            Impact factor:   3.781


  5 in total

Review 1.  Neurogenic bowel dysfunction in patients with spinal cord injury, myelomeningocele, multiple sclerosis and Parkinson's disease.

Authors:  Richard A Awad
Journal:  World J Gastroenterol       Date:  2011-12-14       Impact factor: 5.742

2.  Open surgery for haemorrhoids in persons with spinal cord injury.

Authors:  J G Previnaire; N De Bont; H Bordi; N Senal; P E Mortier
Journal:  Spinal Cord Ser Cases       Date:  2018-04-23

3.  Management of Neurogenic Bowel Dysfunction in Adults after Spinal Cord Injury Suggested citation: Jeffery Johns, Klaus Krogh, Gianna M. Rodriguez, Janice Eng, Emily Haller, Malorie Heinen, Rafferty Laredo, Walter Longo, Wilda Montero-Colon, Mark Korsten. Management of Neurogenic Bowel Dysfunction in Adults after Spinal Cord Injury: Clinical Practice Guideline for Healthcare Providers. Journal of Spinal Cord Med. 2021. Doi:10.1080/10790268.2021.1883385.

Authors:  Jeffery Johns; Klaus Krogh; Gianna M Rodriguez; Janice Eng; Emily Haller; Malorie Heinen; Rafferty Laredo; Walter Longo; Wilda Montero-Colon; Mark Korsten
Journal:  J Spinal Cord Med       Date:  2021-05       Impact factor: 1.985

4.  Management of Neurogenic Bowel Dysfunction in Adults after Spinal Cord Injury: Clinical Practice Guideline for Health Care Providers.

Authors:  Jeffery Johns; Klaus Krogh; Gianna M Rodriguez; Janice Eng; Emily Haller; Malorie Heinen; Rafferty Laredo; Walter Longo; Wilda Montero-Colon; Catherine Wilson; Mark Korsten
Journal:  Top Spinal Cord Inj Rehabil       Date:  2021-05-24

Review 5.  [Guidelines: neurogenic bowel dysfunction in spinal cord injury (long version)].

Authors:  Veronika Geng; Ralf Böthig; Andreas Hildesheim; Ines Kurze; Eckhart Dietrich Leder
Journal:  Coloproctology       Date:  2020-09-11
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.